These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 23748686)
61. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment. Chan FK; Graham DY Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194 [TBL] [Abstract][Full Text] [Related]
62. Guidelines in the medical treatment of Helicobacter pylori infection. Dzieniszewski J; Jarosz M J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112 [TBL] [Abstract][Full Text] [Related]
63. Inflammation in the genesis and perpetuation of atrial fibrillation. Engelmann MD; Svendsen JH Eur Heart J; 2005 Oct; 26(20):2083-92. PubMed ID: 15975993 [TBL] [Abstract][Full Text] [Related]
64. Maintenance treatment with proton pump inhibitors for reflux esophagitis in pediatric patients: a systematic literature analysis. Illueca M; Wernersson B; Henderson C; Lundborg P J Pediatr Gastroenterol Nutr; 2010 Dec; 51(6):733-40. PubMed ID: 20808247 [TBL] [Abstract][Full Text] [Related]
65. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. Savelieva I; Kakouros N; Kourliouros A; Camm AJ Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926 [TBL] [Abstract][Full Text] [Related]
66. Fibrosis, myocardial crossings, disconnections, abrupt turns, and epicardial reflections: do they play an actual role in human permanent atrial fibrillation? A controlled necropsy study. de Oliveira IM; Oliveira BD; Scanavacca MI; Gutierrez PS Cardiovasc Pathol; 2013; 22(1):65-9. PubMed ID: 22917538 [TBL] [Abstract][Full Text] [Related]
67. Non-steroidal anti-inflammatory drugs and the risk of atrial fibrillation: a population-based follow-up study. Krijthe BP; Heeringa J; Hofman A; Franco OH; Stricker BH BMJ Open; 2014 Apr; 4(4):e004059. PubMed ID: 24713211 [TBL] [Abstract][Full Text] [Related]
68. Green tea may be benefit to the therapy of atrial fibrillation. Zeng X; Li Q; Zhang M; Wang W; Tan X J Cell Biochem; 2011 Jul; 112(7):1709-12. PubMed ID: 21381081 [TBL] [Abstract][Full Text] [Related]
69. [Proton pump inhibitor in the management of acid-related disorders in Japan: history and perspective]. Sugano K Nihon Rinsho; 2007 Dec; 65(12):2375-81. PubMed ID: 18069285 [TBL] [Abstract][Full Text] [Related]
70. Chronic atrial dilation, electrical remodeling, and atrial fibrillation in the goat. Neuberger HR; Schotten U; Blaauw Y; Vollmann D; Eijsbouts S; van Hunnik A; Allessie M J Am Coll Cardiol; 2006 Feb; 47(3):644-53. PubMed ID: 16458150 [TBL] [Abstract][Full Text] [Related]
71. Atrial fibrillation in cancer patients: an underrecognized condition. Velagapudi P; Turagam MK; Kocheril AG South Med J; 2011 Sep; 104(9):667-8. PubMed ID: 21886091 [No Abstract] [Full Text] [Related]
72. [Security of proton pump inhibitors]. Martín de Argila de Prados C Rev Esp Enferm Dig; 2011 Feb; 103(2):98. PubMed ID: 21366374 [No Abstract] [Full Text] [Related]
73. Bachmann's bundle: a key player in the development of atrial fibrillation? van Campenhout MJ; Yaksh A; Kik C; de Jaegere PP; Ho SY; Allessie MA; de Groot NM Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):1041-6. PubMed ID: 24129206 [No Abstract] [Full Text] [Related]
74. Current concepts in the pathogenesis of atrial fibrillation. Kourliouros A; Savelieva I; Kiotsekoglou A; Jahangiri M; Camm J Am Heart J; 2009 Feb; 157(2):243-52. PubMed ID: 19185630 [TBL] [Abstract][Full Text] [Related]
75. Atrial fibrillation and gastroesophageal reflux disease: From the cardiologist perspective. Floria M; Drug VL World J Gastroenterol; 2015 Mar; 21(10):3154-6. PubMed ID: 25780320 [TBL] [Abstract][Full Text] [Related]